We had the privilege of attending the Oxford Nanopore Technologies London Calling meeting, where we joined important discussions on genomic equity and the need for diversity in research.
Next stop: ESHG 2025 in Milan. See you there!
#OxfordNanopore#PrecisionMedicine
We’re excited to be part of #PMWC2025 —Our session: “Powering Discoveries in Medicine by Pairing Genetic Diversity with AI-enabled Data Analytics” is part of Track B and will be delivered by our CEO, Carlos D. Bustamante on February 7th at 10:15am PT.
https://t.co/J6Q2N7cBCD
We look forward to attending Sidra Medicine's 10th anniversary of its Precision Medicine and Future Genomics Summit.
⚕️ #PMFG2024: https://t.co/qwAi3AHhEW
Join us at #ASHG2024 to learn how Galatea Bio is advancing biopharma with cutting-edge ancestry algorithms and polygenic risk scores (PRS).
Let’s talk diversity in precision medicine!
#ASHG#Ancestry#PRS
Very proud to see our paper from our team at @GalateaBio on improving PRS across ethnic groups in press. We need more of these tools to enable precision health at scale for all. https://t.co/bxfcYD2Tss
6/ 🙏 Huge thanks to our team at @GalateaBio and collaborators at @genomelink for making this research possible! Dive deeper into the details in our full paper here: https://t.co/bxfcYD2Tss
We at @GalateaBio are thrilled to be partnering with @illumina to build the Biobank of the Americas, a 10 million person participatory cohort to enable precision health at scale for all.
https://t.co/JpakUj9U8y
A Biobank of the Americas: How @GalateaBio is setting its sights on 10 million DNA samples to expand the diversity of genetic datasets, understand disparities and improve health outcomes. https://t.co/UUM3W8Df3j